Altered cognitive-emotional behavior in early experimental autoimmune encephalitis - Cytokine and hormonal correlates

Brain, Behavior, and Immunity

Volumn 33, Issue , 2013, Pages 164-172

  Acharjee, Shaona ^a   Nayani, Nausheen ^a   Tsutsui, Mio ^a   Hill, Matthew N ^a   Ousman, Shalina S ^a   Pittman, Quentin J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anxiety; Cytokines; Depression; EAE; HPA axis; Multiple sclerosis

Indexed keywords

CORTICOSTERONE; INTERLEUKIN 1BETA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; FEAR; FEMALE; FORCED SWIMMING TEST; HYPOTHALAMUS; IMMOBILITY; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOCIAL INTERACTION;

ANXIETY; CYTOKINES; DEPRESSION; EAE; HPA AXIS; MULTIPLE SCLEROSIS;

ANIMALS; BEHAVIOR, ANIMAL; COGNITION DISORDERS; CORTICOSTERONE; CYTOKINES; EARLY DIAGNOSIS; EMOTIONS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERPERSONAL RELATIONS; MICE; MICE, INBRED C57BL; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; REAL-TIME POLYMERASE CHAIN REACTION; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84883805599     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.07.003     Document Type: Article

References (81)

1. Abourbeh G., Theze B., Maroy R., Dubois A., Brulon V., Fontyn Y., Dolle F., Tavitian B., Boisgard R. Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [(1)(8)F]DPA-714. J. Neurosci. 2012, 32:5728-5736.
2. Amato M.P., Portaccio E. Management options in multiple sclerosis-associated fatigue. Expert Opin. Pharmacother. 2012, 13:207-216.
3. Anisman H., Merali Z., Poulter M.O., Hayley S. Cytokines as a precipitant of depressive illness: animal and human studies. Curr. Pharm. Des. 2005, 11:963-972.
4. Barnett M.H., Prineas J.W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 2004, 55:458-468.
5. Bodnoff S.R., Humphreys A.G., Lehman J.C., Diamond D.M., Rose G.M., Meaney M.J. Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J. Neurosci. 1995, 15:61-69.
6. Bolton C., O'Neill J.K., Allen S.J., Baker D. Regulation of chronic relapsing experimental allergic encephalomyelitis by endogenous and exogenous glucocorticoids. Int. Arch. Allergy Immunol. 1997, 114:74-80.
7. Cambron M., D'Haeseleer M., Laureys G., Clinckers R., Debruyne J., De Keyser J. White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis. J. Cereb. Blood Flow Metab. 2012, 32:413-424.
8. Cannella B., Raine C.S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 1995, 37:424-435.
9. Cartmell T., Luheshi G.N., Hopkins S.J., Rothwell N.J., Poole S. Role of endogenous interleukin-1 receptor antagonist in regulating fever induced by localised inflammation in the rat. J. Physiol. 2001, 531:171-180.
10. Chan J.W. Optic neuritis in multiple sclerosis. Ocul. Immunol. Inflamm. 2002, 10:161-186.
11. Coelho M.M., Luheshi G., Hopkins S.J., Pela I.R., Rothwell N.J. Multiple mechanisms mediate antipyretic action of glucocorticoids. Am. J. Physiol. 1995, 269:R527-R535.
12. Compston A., Coles A. Multiple sclerosis. Lancet 2002, 359:1221-1231.
13. Constantinescu C.S., Farooqi N., O'Brien K., Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br. J. Pharmacol. 2011, 164:1079-1106.
14. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
15. Dunn A.J. Effects of cytokines and infections on brain neurochemistry. Clin. Neurosci. Res. 2006, 6:52-68.
16. Fernandes C., McKittrick C.R., File S.E., McEwen B.S. Decreased 5-HT1A and increased 5-HT2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety. Psychoneuroendocrinology 1997, 22:477-491.
17. Gadek-Michalska A., Bugajski J. Interleukin-1 (IL-1) in stress-induced activation of limbic-hypothalamic-pituitary adrenal axis. Pharmacol. Rep. 2010, 62:969-982.
18. Gadek-Michalska A., Tadeusz J., Rachwalska P., Spyrka J., Bugajski J. Brain nitric oxide synthases in the interleukin-1beta-induced activation of hypothalamic-pituitary-adrenal axis. Pharmacol. Rep. 2012, 64:1455-1465.
19. Galic M.A., Riazi K., Henderson A.K., Tsutsui S., Pittman Q.J. Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol. Dis. 2009, 36:343-351.
20. Giatti S., Boraso M., Abbiati F., Ballarini E., Calabrese D., Santos-Galindo M., Rigolio R., Pesaresi M., Caruso D., Viviani B., Cavaletti G., Garcia-Segura L.M., Melcangi R.C. Multimodal analysis in acute and chronic experimental autoimmune encephalomyelitis. J. Neuroimmun. Pharmacol. 2013, 8:238-250.
21. Haji N., Mandolesi G., Gentile A., Sacchetti L., Fresegna D., Rossi S., Musella A., Sepman H., Motta C., Studer V., De Chiara V., Bernardi G., Strata P., Centonze D. TNF-alpha-mediated anxiety in a mouse model of multiple sclerosis. Exp. Neurol. 2012, 237:296-303.
22. Hampton D.W., Anderson J., Pryce G., Irvine K.A., Giovannoni G., Fawcett J.W., Compston A., Franklin R.J., Baker D., Chandran S. An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss. J. Neuroimmunol. 2008, 201-202:200-211.
23. Hill M.N., Brotto L.A., Lee T.T., Gorzalka B.B. Corticosterone attenuates the antidepressant-like effects elicited by melatonin in the forced swim test in both male and female rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27:905-911.
24. Howell O.W., Rundle J.L., Garg A., Komada M., Brophy P.J., Reynolds R. Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. J. Neuropathol. Exp. Neurol. 2010, 69:1017-1033.
25. Hu H., Ho W., Mackie K., Pittman Q.J., Sharkey K.A. Brain CB(1) receptor expression following lipopolysaccharide-induced inflammation. Neuroscience 2012, 227:211-222.
26. Janardhan V., Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J. Neurol. Sci. 2002, 205:51-58.
27. Janssens A.C., van Doorn P.A., de Boer J.B., van der Meche F.G., Passchier J., Hintzen R.Q. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol. Scand. 2003, 108:389-395.
28. Jiang Y., Deacon R., Anthony D.C., Campbell S.J. Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases. Neurobiol. Dis. 2008, 32:125-132.
29. Jongen P.J., Ter Horst A.T., Brands A.M. Cognitive impairment in multiple sclerosis. Minerva Med. 2012, 103:73-96.
30. Kent S., Bluthe R.M., Dantzer R., Hardwick A.J., Kelley K.W., Rothwell N.J., Vannice J.L. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc. Natl. Acad. Sci. USA 1992, 89:9117-9120.
31. Kokras N., Dalla C., Sideris A.C., Dendi A., Mikail H.G., Antoniou K., Papadopoulou-Daifoti Z. Behavioral sexual dimorphism in models of anxiety and depression due to changes in HPA axis activity. Neuropharmacology 2012, 62:436-445.
32. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 2002, 25:154-159.
33. Lassmann H. Experimental models of multiple sclerosis. Rev. Neurol. (Paris) 2007, 163:651-655.
34. Lassmann H., Bruck W., Lucchinetti C.F. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007, 17:210-218.
35. Lassmann H., van Horssen J. The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett. 2011, 585:3715-3723.
36. Lawson M.A., McCusker R.H., Kelley K.W. Interleukin-1 beta converting enzyme is necessary for development of depression-like behavior following intracerebroventricular administration of lipopolysaccharide to mice. J. Neuroinflamm. 2013, 10:54.
37. Leonard J.P., MacKenzie F.J., Patel H.A., Cuzner M.L. Hypothalamic noradrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis. Brain Behav. Immun. 1991, 5:328-338.
38. Levine S., Sowinski R. The role of the adrenal in relapses of experimental allergic encephalomyelitis. Proc. Soc. Exp. Biol. Med. 1975, 149:1032-1035.
39. Lidow M.S., Song Z.M., Ren K. Long-term effects of short-lasting early local inflammatory insult. NeuroReport 2001, 12:399-403.
40. Linthorst A.C., Karanth S., Barden N., Holsboer F., Reul M.H. Impaired glucocorticoid receptor function evolves in aberrant physiological responses to bacterial endotoxin. Eur. J. Neurosci. 1999, 11:178-186.
41. Lobentanz I.S., Asenbaum S., Vass K., Sauter C., Klosch G., Kollegger H., Kristoferitsch W., Zeitlhofer J. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol. Scand. 2004, 110:6-13.
42. Luheshi G., Miller A.J., Brouwer S., Dascombe M.J., Rothwell N.J., Hopkins S.J. Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Am. J. Physiol. 1996, 270:E91-E95.
43. MacPhee I.A., Antoni F.A., Mason D.W. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 1989, 169:431-445.
44. Maier S.F. Bi-directional immune-brain communication: implications for understanding stress, pain, and cognition. Brain Behav. Immun. 2003, 17:69-85.
45. Mangano E.N., Hayley S. Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: neuroimmune sensitization of neurodegeneration. Neurobiol. Aging 2009, 30:1361-1378.
46. Martino G., Adorini L., Rieckmann P., Hillert J., Kallmann B., Comi G., Filippi M. Inflammation in multiple sclerosis: the good, the bad, and the complex. Lancet Neurol. 2002, 1:499-509.
47. Martino G., Furlan R., Brambilla E., Bergami A., Ruffini F., Gironi M., Poliani P.L., Grimaldi L.M., Comi G. Cytokines and immunity in multiple sclerosis: the dual signal hypothesis. J. Neuroimmunol. 2000, 109:3-9.
48. Matejuk A., Dwyer J., Ito A., Bruender Z., Vandenbark A.A., Offner H. Effects of cytokine deficiency on chemokine expression in CNS of mice with EAE. J. Neurosci. Res. 2002, 67:680-688.
49. Miljkovic D., Timotijevic G., Mostarica Stojkovic M. Astrocytes in the tempest of multiple sclerosis. FEBS Lett. 2011, 585:3781-3788.
50. Miller E. Multiple sclerosis. Adv. Exp. Med. Biol. 2012, 724:222-238.
51. Min W., Liu C., Yang Y., Sun X., Zhang B., Xu L., Sun X. Alterations in hypothalamic-pituitary-adrenal/thyroid (HPA/HPT) axes correlated with the clinical manifestations of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 39:206-211.
52. Moore P., Hirst C., Harding K.E., Clarkson H., Pickersgill T.P., Robertson N.P. Multiple sclerosis relapses and depression. J. Psychosom. Res. 2012, 73:272-276.
53. Morrow L.E., McClellan J.L., Klir J.J., Kluger M.J. The CNS site of glucocorticoid negative feedback during LPS- and psychological stress-induced fevers. Am. J. Physiol. 1996, 271:R732-R737.
54. Murphy A.C., Lalor S.J., Lynch M.A., Mills K.H. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav. Immun. 2010, 24:641-651.
55. Murugesan N., Paul D., Lemire Y., Shrestha B., Ge S., Pachter J.S. Active induction of experimental autoimmune encephalomyelitis by MOG35-55 peptide immunization is associated with differential responses in separate compartments of the choroid plexus. Fluids Barriers CNS 2012, 9:15.
56. Nadeau S., Rivest S. The complement system is an integrated part of the natural innate immune response in the brain. FASEB J. 2001, 15:1410-1412.
57. O'Connor J.C., Lawson M.A., Andre C., Moreau M., Lestage J., Castanon N., Kelley K.W., Dantzer R. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 2009, 14:511-522.
58. Olechowski C.J., Truong J.J., Kerr B.J. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain 2009, 141:156-164.
59. Ousman S.S., Tomooka B.H., van Noort J.M., Wawrousek E.F., O'Connor K.C., Hafler D.A., Sobel R.A., Robinson W.H., Steinman L. Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature 2007, 448:474-479.
60. Palin K., Bluthe R.M., McCusker R.H., Moos F., Dantzer R., Kelley K.W. TNFalpha-induced sickness behavior in mice with functional 55 kD TNF receptors is blocked by central IGF-I. J. Neuroimmunol. 2007, 187:55-60.
61. Paparrigopoulos T., Ferentinos P., Kouzoupis A., Koutsis G., Papadimitriou G.N. The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour. Int. Rev. Psychiatry 2010, 22:14-21.
62. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 1985, 14:149-167.
63. Peruga I., Hartwig S., Thöne J., Hovemann B., Gold R., Juckel G., Linker R.A. Inflammation modulates anxiety in an animal model of multiple sclerosis. Behav. Brain Res. 2011, 220:20-29.
64. Pollak D.D., Rey C.E., Monje F.J. Rodent models in depression research: classical strategies and new directions. Ann. Med. 2010, 42:252-264.
65. Pollak Y., Orion E., Goshen I., Ovadia H., Yirmiya R. Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of 'depression due to multiple sclerosis'. Brain Behav. Immun. 2002, 16:533-543.
66. Pollak Y., Ovadia H., Orion E., Weidenfeld J., Yirmiya R. The EAE-associated behavioral syndrome: I. Temporal correlation with inflammatory mediators. J. Neuroimmunol. 2003, 137:94-99.
67. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 1977, 229:327-336.
68. Quinn T.A., Dutt M., Shindler K.S. Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis. Front. Neurol. 2011, 2:50.
69. Rasmussen S., Wang Y., Kivisakk P., Bronson R.T., Meyer M., Imitola J., Khoury S.J. Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing-remitting experimental autoimmune encephalomyelitis. Brain 2007, 130:2816-2829.
70. Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 2001, 26:761-788.
71. Sakai R.E., Feller D.J., Galetta K.M., Galetta S.L., Balcer L.J. Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J. Neuroophthalmol. 2011, 31:362-373.
72. Schafers M., Sorkin L. Effect of cytokines on neuronal excitability. Neurosci. Lett. 2008, 437:188-193.
73. Simard A.R., Rivest S. Do pathogen exposure and innate immunity cause brain diseases?. Neurol. Res. 2005, 27:717-725.
74. Simen B.B., Duman C.H., Simen A.A., Duman R.S. TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol. Psychiatry 2006, 59:775-785.
75. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 2007, 27:10695-10702.
76. Sriram S. Role of glial cells in innate immunity and their role in CNS demyelination. J. Neuroimmunol. 2011, 239:13-20.
77. Sutton C., Brereton C., Keogh B., Mills K.H., Lavelle E.C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 2006, 203:1685-1691.
78. Tatro J.B. Endogenous antipyretics. Clin. Infect. Dis. 2000, 31(Suppl. 5):S190-S201.
79. Van Der Voorn P., Tekstra J., Beelen R.H., Tensen C.P., Van Der Valk P., De Groot C.J. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. Am. J. Pathol. 1999, 154:45-51.
80. Vattakatuchery J.J., Rickards H., Cavanna A.E. Pathogenic mechanisms of depression in multiple sclerosis. J. Neuropsychiatry Clin. Neurosci. 2011, 23:261-276.
81. Yang G., Parkhurst C.N., Hayes S., Gan W.B. Peripheral elevation of TNF-alpha leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2013, 110:10306-10311.